Your browser doesn't support javascript.
loading
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer.
Cave, Donatella Delle; Buonaiuto, Silvia; Sainz, Bruno; Fantuz, Marco; Mangini, Maria; Carrer, Alessandro; Di Domenico, Annalisa; Iavazzo, Tea Teresa; Andolfi, Gennaro; Cortina, Carme; Sevillano, Marta; Heeschen, Christopher; Colonna, Vincenza; Corona, Marco; Cucciardi, Antonio; Di Guida, Martina; Batlle, Eduard; De Luca, Annachiara; Lonardo, Enza.
Afiliación
  • Cave DD; Institute of Genetics and Biophysics "A. Buzzati-Traverso", National Research Council (CNR-IGB), 80131, Naples, Italy. donatella.dellecave@igb.cnr.it.
  • Buonaiuto S; Institute of Genetics and Biophysics "A. Buzzati-Traverso", National Research Council (CNR-IGB), 80131, Naples, Italy.
  • Sainz B; Department of Cancer Biology, Instituto de Investigaciones Biomedicas "Alberto Sols" (IIBM), CSIC-UAM, 28029, Madrid, Spain.
  • Fantuz M; Chronic Diseases and Cancer, Area 3-Instituto Ramon Y Cajal de Investigacion Sanitaria (IRYCIS), 28034, Madrid, Spain.
  • Mangini M; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, 28029, Madrid, Spain.
  • Carrer A; Department of Biology, University of Padova, 35129, Padova, Italy.
  • Di Domenico A; Veneto Institute of Molecular Medicine (VIMM), 35129, Padova, Italy.
  • Iavazzo TT; Institute for Experimental Endocrinology and Oncology, "G. Salvatore" (IEOS), Second Unit, Consiglio Nazionale Delle Ricerche (CNR), 801310, Naples, Italy.
  • Andolfi G; Department of Biology, University of Padova, 35129, Padova, Italy.
  • Cortina C; Veneto Institute of Molecular Medicine (VIMM), 35129, Padova, Italy.
  • Sevillano M; Institute of Genetics and Biophysics "A. Buzzati-Traverso", National Research Council (CNR-IGB), 80131, Naples, Italy.
  • Heeschen C; Institute of Genetics and Biophysics "A. Buzzati-Traverso", National Research Council (CNR-IGB), 80131, Naples, Italy.
  • Colonna V; Institute of Genetics and Biophysics "A. Buzzati-Traverso", National Research Council (CNR-IGB), 80131, Naples, Italy.
  • Corona M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028, Barcelona, Spain.
  • Cucciardi A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 08028, Barcelona, Spain.
  • Di Guida M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028, Barcelona, Spain.
  • Batlle E; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 08028, Barcelona, Spain.
  • De Luca A; State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Lonardo E; Institute of Genetics and Biophysics "A. Buzzati-Traverso", National Research Council (CNR-IGB), 80131, Naples, Italy.
J Exp Clin Cancer Res ; 41(1): 315, 2022 Oct 26.
Article en En | MEDLINE | ID: mdl-36289544
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Italia